IgM and IgA anti-erythrocyte autoantibodies induce anemia in a mouse model through multivalency-dependent hemagglutination but not through complement activation

Blood

Volumn 109, Issue 12, 2007, Pages 5355-5362

  Baudino, Lucie ^a   Fossati Jimack, Liliane ^b   Chevalley, Christelle ^a   Martinez Soria, Eduardo ^a   Shulman, Marc J ^c   Izui, Shozo ^a,d  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c UNIVERSITY OF TORONTO   (Canada)

^d CMU   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; ERYTHROCYTE; ERYTHROPHAGOCYTOSIS; HEMAGGLUTINATION; IMMUNOPATHOGENESIS; KUPFFER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

EID: 34249998119     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-11-059899     Document Type: Article

References (48)

1. Howie JB, Helyer BJ. The immunology and pathology of NZB mice. Adv Immunol. 1968;9:215-266.
2. Izui S. Autoimmune hemolytic anemia. Curr Opin Immunol. 1994;6:926-930.
3. Linder E, Edgington TS. Antigen specificity of anti-erythrocyte autoantibody responses of NZB mice: identification and partial characterization of two erythrocyte surface autoantigens. J Immunol. 1972;108:1615-1623.
4. Clynes R, Ravetch JV. Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity. 1995;3:21-26.
5. Meyer D, Schiller C, Westermann J, et al. FcγRIII (CD16)-deficient mice show IgG isotope-dependent protection to experimental autoimmune hemolytic anemia. Blood. 1998;92:3997-4002.
6. Fossati-Jimack L, Reininger L, Chicheportiche Y, et al. High pathogenic potential of low-affinity autoantibodies in experimental autoimmune hemolytic anemia. J Exp Med. 1999;190:1689-1696.
7. Fossati-Jimack L, Ioan-Facsinay A, Reininger L, et al. Markedly different pathogenicity of four IgG isotype-switch variants of an anti-erythrocyte autoantibody is based on their respective capacity to interact in vivo with the low-affinity FcγRIII. J Exp Med. 2000;191:1293-1302.
8. Azeredo da Silveira S, Kikuchi S, Fossati-Jimack L, et al. Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody. J Exp Med. 2002;195:665-672.
9. Shibata T, Berney T, Reininger L, et al. Monoclonal anti-erythrocyte autoantibodies derived from NZB mice cause autoimmune hemolytic anemia by two distinct pathogenic mechanisms. Int Immunol. 1990;2:1133-1141.
10. Mestecky J, McGhee JR. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol. 1987;40:153-245.
11. Johnson S, Opstad NL, Douglas JM Jr, Janoff EN. Prolonged and preferential production of polymeric immunoglobulin A in response to Streptococcus pneumoniae capsular polysaccharides. Infect Immun. 1996;64:4339-4344.
12. Mostov KE. Transepithelial transport of immunoglobulins. Annu Rev Immunol. 1994;12:63-84.
13. Shibuya A, Sakamoto N, Shimizu Y, et al. Fcα/μ receptor mediates endocytosis of IgM-coated microbes. Nat Immunol. 2000;1:441-446.
14. Moore JS, Hoover RG. Defective isotype-specific regulation of IgA anti-erythrocyte autoantibody-forming cells in NZB mice. J Immunol. 1989;142:4282-4288.
15. Wessels MR, Butko P, Ma M, Warren HB, Lage AL, Carroll MC. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci USA. 1995;92:11490-11494.
16. Nimmerjahn F, Ravetch JV. Fcγ receptors: old friends and new family members. Immunity. 2006;24:19-28.
17. Park SY, Ueda S, Ohno H, et al. Resistance of Fc receptor-deficient mice to fatal glomerulonephritis. J Clin Invest. 1998;102:1229-1238.
18. Neuberger MS. Expression and regulation of immunoglobulin heavy gene transfected into lymphoid cells. EMBO J. 1983;2:1373-1378.
19. Simon T, Rajewsky K. 'Enhancer-constitutive' vectors for the expression of recombinant antibodies. Nucleic Acids Res. 1988;16:354.
20. Okamoto M, Murakami M, Shimizu A, et al. A transgenic model of autoimmune hemolytic anemia. J Exp Med. 1992;175:71-79.
21. Nishida Y, Kataoka T, Ishida N, et al. Cloning of mouse immunoglobulin epsilon gene and its location within the heavy chain gene cluster. Proc Natl Acad Sci USA. 1981;78:1581-1585.
22. Wiersma EJ, Shulman MJ. Assembly of IgM. Role of disulfide bonding and noncovalent interactions. J Immunol. 1995;154:5265-5272.
23. Kuroki A, Kuroda Y, Kikuchi S, et al. Level of galactosylation determines cryoglobulin activity of murine IgG3 monoclonal rheumatoid factor. Blood. 2002;99:2922-2928.
24. Ozaki S, Nagasawa R, Sato H, Shirai T. Hybridoma autoantibodies to erythrocytes from NZB mice and the induction of hemolytic anemia. Immunol Lett. 1984;8:115-119.
25. Atkin JD, Pleass RJ, Owens RJ, Woof JM. Mutagenesis of the human IgA1 heavy chain tailpiece that prevents dimer assembly. J Immunol. 1996;157:156-159.
26. Holt DS, Botto M, Bygrave AE, Hanna SM, Walport MJ, Morgan BP. Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood. 2001;98:442-449.
27. Harboe M. A method for determination of hemoglobin in plasma by near-ultraviolet spectrophotometry. Scand J Clin Lab Invest. 1959;11:66-70.
28. Morton HC, van den Herik-Oudijk IE, Vossebeld P, et al. Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR γ chain. Molecular basis for CD89/FcR γ chain association. J Biol Chem. 1995;270:29781-29787.
29. Van Egmond M, Van Vuuren AJ, Morton HC, et al. Human immunoglobulin A receptor (FcαRI, CD89) function in transgenic mice requires both FcR γ chain and CR3 (CD11b/CD18). Blood. 1999;93:4387-4394.
30. Molina H, Miwa T, Zhou L, et al. Complementmediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor. Blood. 2002;100:4544-4549.
31. Miwa T, Zhou L, Hilliard B, Molina H, Song WC. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Blood. 2002;99:3707-3716.
32. Bindon CI, Hale G, Waldmann H. Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies. Eur J Immunol. 1988;18:1507-1514.
33. Waterbury L, Parnes H, Katz RS. Fatal warm antibody autoimmune hemolysis with marked erythrocyte autoagglutination and liver necrosis. South Med J. 1986;79:646-647.
34. Freedman J, Wright J, Lim FC, Garvey MB. Hemolytic warm IgM autoagglutinins in autoimmune hemolytic anemia. Transfusion. 1987;27:464-467.
35. Shirey RS, Kickler TS, Bell W, Little B, Smith B, Ness PM. Fatal immune hemolytic anemia and hepatic failure associated with a warm-reacting IgM autoantibody. Vox Sang. 1987;52:219-222.
36. McCann EL, Shirey RS, Kickler TS, Ness PM. IgM autoagglutinins in warm autoimmune hemolytic anemia: a poor prognostic feature. Acta Haematol. 1992;88:120-125.
37. Garratty G, Arndt P, Domen R, et al. Severe autoimmune hemolytic anemia associated with IgM warm autoantibodies directed against determinants on or associated with glycophorin A. Vox Sang. 1997;72:124-130.
38. Friedmann AM, King KE, Shirey RS, Resar LM, Casella JF. Fatal autoimmune hemolytic anemia in a child due to warm-reactive immunoglobulin M antibody. J Pediatr Hematol Oncol. 1998;20:502-505.
39. Miller MR, Thompson WR, Casella JF, Spevak PJ. Antibody-mediated red blood cell agglutination resulting in spontaneous echocardiographic contrast. Pediatr Cardiol. 1999;20:287-289.
40. Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol. 2002;69:258-271.
41. Cohen PL. Bone marrow as the major site of antierythrocyte autoantibody production in NZB mice. Arthritis Rheum. 1980;23:1045-1048.
42. Moll T, Martinez-Soria E, Santiago-Raber ML, et al. Differential activation of anti-erythrocyte and anti-DNA autoreactive B lymphocytes by the Yaa mutation. J Immunol. 2005;174:702-709.
43. Maruoka T, Nagata T, Kasahara M. Identification of the rat IgA Fc receptor encoded in the leukocyte receptor complex. Immunogenetics. 2004;55:712-716.
44. Renegar KB, Jackson GD, Mestecky J. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA. J Immunol. 1998;160:1219-1223.
45. Monteiro RC, Van de Winkel JG. IgA Fc receptors. Annu Rev Immunol. 2003;21:177-204.
46. Hiemstra PS, Gorter A, Stuurman ME, Van Es LA, Daha MR. Activation of the alternative pathway of complement by human serum IgA. Eur J Immunol. 1987;17:321-326.
47. Janoff EN, Fasching C, Orenstein JM, Rubins JB, Opstad NL, Dalmasso AP. Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes. J Clin Invest. 1999;104:1139-1147.
48. Roos A, Bouwman LH, van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR. Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol. 2001;167:2861-2868.